Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SRT2104 Safety and PK in Type 2 Diabetes
NCT00937326Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of SRT2104 in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Aug 2009; status: completed.
02
Drugs
SRT2104
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00937326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00937326.